ProPhase Labs, Inc. (PRPH) has a consensus analyst rating of Buy, based on 2 analysts covering the stock. Of those, 1 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for PRPH is $14.00, representing a +9,214.7% upside from the current price of $0.1503. Price targets range from a low of $14.00 to a high of $14.00.
